Immunotherapy in Older Adults with Cancer
Author:
Funder
National Cancer Institute
Publisher
Springer Science and Business Media LLC
Subject
Oncology
Link
http://link.springer.com/content/pdf/10.1007/s11912-019-0806-2.pdf
Reference46 articles.
1. Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA. Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol Off J Am Soc Clin Oncol. 2009;27(17):2758–65.
2. Scher KS, Hurria A. Under-representation of older adults in cancer registration trials: known problem, little progress. J Clin Oncol Off J Am Soc Clin Oncol. 2012;30(17):2036–8.
3. • Mohile SG, Dale W, Somerfield MR, Schonberg MA, Boyd CM, Burhenn PS, et al. Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: ASCO Guideline for Geriatric Oncology. J Clin Oncol Off J Am Soc Clin Oncol. 2018:JCO2018788687. Recent ASCO guidelines on the use of geriatric assessment in the management of older adults in oncology.
4. Jolly TA, Deal AM, Nyrop KA, Williams GR, Pergolotti M, Wood WA, et al. Geriatric assessment-identified deficits in older cancer patients with normal performance status. Oncologist. 2015;20(4):379–85.
5. Kimmick GG, Fleming R, Muss HB, Balducci L. Cancer chemotherapy in older adults. A tolerability perspective. Drugs Aging. 1997;10(1):34–49.
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Inclusion, characteristics, and reporting of older adults in FDA registration studies of immunotherapy, 2018–2022;Journal for ImmunoTherapy of Cancer;2024-08
2. Ageing-related considerations for medication used in supportive care in cancer;Journal of Geriatric Oncology;2024-06
3. Immune Checkpoint Inhibitors in Geriatric Oncology;Current Oncology Reports;2024-04-08
4. Effectiveness and Safety of Immune Checkpoint Inhibitors in Older Cancer Patients;Journal of Personalized Medicine;2024-03-01
5. Immunotherapy in Older Patients with Cancer: A Narrative Review;International Journal of General Medicine;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3